Science

Delta virus variant, which took over in the UK and threatens the US, doubles the risk of hospitalization, new data says. But vaccines are still effective.

A health professionals gives a woman wearing a mask a COVID-19 vaccine in the arm in Scotland.
A woman receives a COVID–19 vaccination in Glasgow, Scotland on May 14, 2021. Jeff J Mitchell - Pool/Getty Images
Read in app

The Delta variant of the coronavirus is linked to an 85% higher risk of hospitalization, according to a new study from part of the UK.

The findings from Scotland were published in the peer-reviewed medical journal The Lancet on Monday.

Around the same time UK Prime Minister Boris Johnson delayed easing final lockdown restrictions for another four weeks, citing concerns about the fast-spreading variant.

This variant, also known to scientists as B.1.617.2, was first identified in India. It is 60% more transmissible than the variant Alpha (B.1.1.7, first seen in the UK), which had been dominant in the UK but was fast supplanted by the Delta variant.

Delta can now be found in 74 countries, and US officials have warned that it could become dominant in the US.

In the UK, the latest data showed that Delta was to blame for more than 90% of new cases.

Last week, Dr. Antony Fauci, the White House chief medical advisor, warned that the Delta variant, then behind 6% of US cases, could become dominant in the US if people don't get fully vaccinated.

Although the new variant appeared more dangerous, vaccines still help.

Another dataset released by Public Health England the same day showed that vaccines are still effective, albeit to a lesser extent than with earlier variants.

To calculate the increased hospitalization risk, researchers from the University of Edinburgh and Public Health Scotland looked at records from EAVE-II, a surveillance database that tracks COVID-19 cases in Scotland.

The researchers looked at 19,543 confirmed infections, a little fewer than half of which were the Delta variant.

After adjusting for factors such as sex, deprivation, age, and comorbidities, the scientists found that people with the Delta variant were 85% more likely to be hospitalized. 

According to the study, the Pfizer and AstraZeneca vaccines provided 79% and 60% protection each, down from 93% and 73% respectively with the previously-widespread Alpha variant.

The authors warned that their data on vaccines was preliminary, and other tests may find different figures.

Read next

Doctor Marianne Guenot is a science reporter based in the UK who writes about health, AI, nuclear sciences, archeology, solar and planetary sciences, space exploration, and the commercial and political impact of science and tech. As part of her work, she visited the world's first final repository for nuclear waste, probed the economy of the climate crisis, untangled the complex factors playing into how the food chain pushes a health and climate crisis, tracked mysterious uranium cubes from the Manhattan project back to a Germany first prototype nuclear reactor, examined the motivations behind a tech tycoon's disastrous exploration of the deep sea, and deciphered the intricate business case behind NASA's return to the moon.Marianne holds a master's and Ph.D. in biomedicine and a master's degree in science communication. She worked with Business Insider from 2021 to 2024. Before then, she edited news and opinion at The Lancet and Nature Medicine. There, she wrote editorials read by leading policymakers. Selected works include.